Aclaris Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €36.90M +273.1% -€103.45M +9.6% -280.4% +6.7 pp N/A N/A
    (estimated) €9.89M +73.4% -€94.43M +18.2% -954.7% +4.5 pp N/A N/A
    (estimated) €5.70M +20.6% -€79.91M +23.3% -1,401.1% -0.31 pp N/A N/A
    (estimated) €4.73M -6.6% -€64.79M +16.4% -1,369.8% -2.7 pp N/A N/A
    (estimated) €5.07M -68.6% -€55.65M -51.1% -1,098.5% -3.9 pp N/A N/A
    €16.13M -40.1% -€113.78M +49.3% -705.5% -4.2 pp -€17.19M -74.1% -106.6% +1.4 pp
    €26.92M +5.0% -€76.23M -0.2% -283.1% +0.15 pp -€66.35M +15.0% -246.5% -0.21 pp
    €25.63M +340.1% -€76.39M -22.4% -298.0% +14 pp -€57.69M +29.2% -225.1% +5.4 pp
    €5.82M +4.3% -€98.46M +123.4% -1,690.3% -9.0 pp -€44.65M +35.7% -766.5% -1.8 pp
    €5.58M +53.3% -€44.07M -64.2% -789.2% +26 pp -€32.89M -59.7% -589.0% +17 pp
    €3.64M -58.1% -€123.07M +7.6% -3,379.5% -21 pp -€81.70M -4.6% -2,243.5% -13 pp
    €8.69M +499.6% -€114.36M +93.7% -1,315.4% +28 pp -€85.69M +86.1% -985.6% +22 pp
    €1.45M +∞% -€59.04M +42.5% -4,071.5% -41 pp -€46.03M +55.4% -3,174.6% -32 pp
    €0.00 +NaN% -€41.42M +133.8% N/A -€29.61M +73.0% N/A
    €0.00 +NaN% -€17.72M +141.4% N/A -€17.11M +175.1% N/A
    €0.00 +NaN% -€7.34M +62.7% N/A -€6.22M +46.7% N/A
    €0.00 -€4.51M N/A -€4.24M N/A

    Notifications